On March 28, FDA again updated its FAQ regarding specimen collection for COVID-19 testing.
FDA continues to issue additional Emergency Use Authorizations for diagnostic tests for COVID-19 including an additional point-of-care test. As of the morning of March 30, twenty tests now have received EUAs.
FAQs on Diagnostic Testing for SARS-CoV-2
In Vitro Diagnostics EUAs